FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:IGF1R-PPP4R1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: IGF1R-PPP4R1
FusionPDB ID: 38488
FusionGDB2.0 ID: 38488
HgeneTgene
Gene symbol

IGF1R

PPP4R1

Gene ID

3480

9989

Gene nameinsulin like growth factor 1 receptorprotein phosphatase 4 regulatory subunit 1
SynonymsCD221|IGFIR|IGFR|JTK13MEG1|PP4(Rmeg)|PP4R1
Cytomap

15q26.3

18p11.22

Type of geneprotein-codingprotein-coding
Descriptioninsulin-like growth factor 1 receptorIGF-I receptorsoluble IGF1R variant 1soluble IGF1R variant 2serine/threonine-protein phosphatase 4 regulatory subunit 1serine/threonine phosphatase 4
Modification date2020032920200313
UniProtAcc

P08069

Main function of 5'-partner protein: FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.; FUNCTION: When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin.
.
Ensembl transtripts involved in fusion geneENST idsENST00000268035, ENST00000558762, 
ENST00000560432, 
ENST00000400555, 
ENST00000580583, ENST00000400556, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score24 X 15 X 6=216017 X 14 X 9=2142
# samples 2517
** MAII scorelog2(25/2160*10)=-3.11103131238874
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(17/2142*10)=-3.65535182861255
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: IGF1R [Title/Abstract] AND PPP4R1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: IGF1R [Title/Abstract] AND PPP4R1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)IGF1R(99467913)-PPP4R1(9595151), # samples:2
Anticipated loss of major functional domain due to fusion event.IGF1R-PPP4R1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IGF1R-PPP4R1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IGF1R-PPP4R1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
IGF1R-PPP4R1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneIGF1R

GO:0043066

negative regulation of apoptotic process

12556535

HgeneIGF1R

GO:0046328

regulation of JNK cascade

12556535

HgeneIGF1R

GO:0046777

protein autophosphorylation

1846292|7679099|11162456

HgeneIGF1R

GO:0048009

insulin-like growth factor receptor signaling pathway

7679099

HgeneIGF1R

GO:0048015

phosphatidylinositol-mediated signaling

7692086

HgeneIGF1R

GO:0051389

inactivation of MAPKK activity

12556535



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr15:99467913/chr18:9595151)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across IGF1R (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PPP4R1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000268035IGF1Rchr1599467913+ENST00000400556PPP4R1chr189595151-7192339361161931860
ENST00000558762IGF1Rchr1599467913+ENST00000400556PPP4R1chr189595151-7119332053861201860

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000268035ENST00000400556IGF1Rchr1599467913+PPP4R1chr189595151-0.0015248920.99847513
ENST00000558762ENST00000400556IGF1Rchr1599467913+PPP4R1chr189595151-0.0014092890.99859065

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for IGF1R-PPP4R1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
IGF1Rchr1599467913PPP4R1chr1895951513320928WTDPVFFYVQAKIGVDDYSSESDVII
IGF1Rchr1599467913PPP4R1chr1895951513393928WTDPVFFYVQAKIGVDDYSSESDVII

Top

Potential FusionNeoAntigen Information of IGF1R-PPP4R1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IGF1R-PPP4R1_99467913_9595151.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:01VQAKIGVDDY0.9990.5803818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:25VQAKIGVDDY0.94390.696818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:05VQAKIGVDDY0.80990.5505818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B35:43QAKIGVDDY0.97490.5886918
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-C14:03FYVQAKIGV0.14590.8072615
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-C14:02FYVQAKIGV0.14590.8072615
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:34VQAKIGVDDY0.9990.5803818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:33VQAKIGVDDY0.9990.5803818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:125VQAKIGVDDY0.9990.5803818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:27VQAKIGVDDY0.99890.6441818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:135VQAKIGVDDY0.99890.6274818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:50VQAKIGVDDY0.99840.5904818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:35VQAKIGVDDY0.99490.5434818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:12VQAKIGVDDY0.99440.6503818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:53VQAKIGVDDY0.9880.5268818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B15:20VQAKIGVDDY0.81220.6508818
IGF1R-PPP4R1chr1599467913chr1895951513393HLA-B35:28VQAKIGVDDY0.7860.6696818

Top

Potential FusionNeoAntigen Information of IGF1R-PPP4R1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IGF1R-PPP4R1_99467913_9595151.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0101DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0103DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0103TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0103PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0105DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0107DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0109DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0109TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0111DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0113DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0113TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0115DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0115TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0117DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0117TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0119DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0121DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0121TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0125DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0127DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0129DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0129TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0131DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0447DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0447TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0454DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0454TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0482DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0486DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0701DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0703DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0704DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0705DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0706DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0706TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0707DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0708DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0709DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0709TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0711DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0711TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0712DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0713DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0714DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0715DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0716DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0717DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0719DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0803DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0807DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0807PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0808DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0811DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0813DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0814DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0815DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0819DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0819TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0823DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0825DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0827DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0830DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0832DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0833DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0834DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0834TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0835DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0836DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0837DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0838DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0901DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0902DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0903DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0903PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0903VFFYVQAKIGVDDYS419
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0905DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0907DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0908DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0908PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0908VFFYVQAKIGVDDYS419
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-0909DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1001DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1001TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1003DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1003TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1119DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1130DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1130TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1130PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1131DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1145DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1164DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1172DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1182DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1182PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1216DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-13100DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1331DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1346DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1367DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1382DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1386DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1402DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1402PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1403DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1409DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1424DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1430DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1440DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1441DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1441PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1446DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1446PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1447DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1447PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1449DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1449PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1463DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1467DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1468DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1477DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1489DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1493DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1494DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1494PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1498DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1515DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1527DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1601DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1601TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1602DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1602TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1603DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1603TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1604DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1604TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1604PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1605DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1605TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1607DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1607TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1608DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1608TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1609DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1609TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1609PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1610DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1610TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1611DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1611TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1612DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1612TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1614DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1614TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1616DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB1-1616TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0102DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0102TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0102PVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0103DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0103TDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0104DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0108NDPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0108NTDPVFFYVQAKIGVD116
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0108NPVFFYVQAKIGVDDY318
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0112DPVFFYVQAKIGVDD217
IGF1R-PPP4R1chr1599467913chr1895951513393DRB5-0203DPVFFYVQAKIGVDD217

Top

Fusion breakpoint peptide structures of IGF1R-PPP4R1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2630FYVQAKIGVDDYSSIGF1RPPP4R1chr1599467913chr1895951513393

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of IGF1R-PPP4R1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2630FYVQAKIGVDDYSS-7.15543-7.26883
HLA-B14:023BVN2630FYVQAKIGVDDYSS-4.77435-5.80965
HLA-B52:013W392630FYVQAKIGVDDYSS-6.80875-6.92215
HLA-B52:013W392630FYVQAKIGVDDYSS-4.20386-5.23916
HLA-A11:014UQ22630FYVQAKIGVDDYSS-7.5194-8.5547
HLA-A11:014UQ22630FYVQAKIGVDDYSS-6.9601-7.0735
HLA-A24:025HGA2630FYVQAKIGVDDYSS-7.52403-7.63743
HLA-A24:025HGA2630FYVQAKIGVDDYSS-5.82433-6.85963
HLA-B27:056PYJ2630FYVQAKIGVDDYSS-3.28285-4.31815
HLA-B44:053DX82630FYVQAKIGVDDYSS-5.91172-6.94702
HLA-B44:053DX82630FYVQAKIGVDDYSS-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of IGF1R-PPP4R1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
IGF1R-PPP4R1chr1599467913chr189595151615FYVQAKIGVTCTTCTATGTCCAGGCCAAAATTGGTG
IGF1R-PPP4R1chr1599467913chr189595151818VQAKIGVDDYATGTCCAGGCCAAAATTGGTGTGGATGACT
IGF1R-PPP4R1chr1599467913chr189595151918QAKIGVDDYTCCAGGCCAAAATTGGTGTGGATGACT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
IGF1R-PPP4R1chr1599467913chr189595151116TDPVFFYVQAKIGVDGGACAGATCCTGTGTTCTTCTATGTCCAGGCCAAAATTGGTGTGG
IGF1R-PPP4R1chr1599467913chr189595151217DPVFFYVQAKIGVDDCAGATCCTGTGTTCTTCTATGTCCAGGCCAAAATTGGTGTGGATG
IGF1R-PPP4R1chr1599467913chr189595151318PVFFYVQAKIGVDDYATCCTGTGTTCTTCTATGTCCAGGCCAAAATTGGTGTGGATGACT
IGF1R-PPP4R1chr1599467913chr189595151419VFFYVQAKIGVDDYSCTGTGTTCTTCTATGTCCAGGCCAAAATTGGTGTGGATGACTACA

Top

Information of the samples that have these potential fusion neoantigens of IGF1R-PPP4R1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAIGF1R-PPP4R1chr1599467913ENST00000268035chr189595151ENST00000400556TCGA-E9-A1NF-01A

Top

Potential target of CAR-T therapy development for IGF1R-PPP4R1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to IGF1R-PPP4R1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to IGF1R-PPP4R1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource